Trial · NCT01019694
Results by group141
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 141
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 48 | Combivent Respimat | 87.9 | Standard Error 1.27 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 48 | Combivent Inhalation Aerosol | 78.3 | Standard Error 1.31 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 48 | Atrovent + Albuterol Aerosols | 81.7 | Standard Error 1.37 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | Combivent Respimat | 84.7 | Standard Error 1.07 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | Combivent Inhalation Aerosol | 79.4 | Standard Error 1.09 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | Atrovent + Albuterol Aerosols | 77.3 | Standard Error 1.08 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 12 | Combivent Respimat | 85.9 | Standard Error 1.14 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 12 | Combivent Inhalation Aerosol | 78.0 | Standard Error 1.15 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 12 | Atrovent + Albuterol Aerosols | 76.3 | Standard Error 1.16 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 24 | Combivent Respimat | 86.6 | Standard Error 1.15 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 24 | Combivent Inhalation Aerosol | 77.5 | Standard Error 1.16 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 24 | Atrovent + Albuterol Aerosols | 78.9 | Standard Error 1.19 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 36 | Combivent Respimat | 88.2 | Standard Error 1.22 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 36 | Combivent Inhalation Aerosol | 76.9 | Standard Error 1.24 | unit on a scale | |
| Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 36 | Atrovent + Albuterol Aerosols | 80.5 | Standard Error 1.29 | unit on a scale | |
| Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 0 | Combivent Respimat | 5.8 | Standard Deviation 1.21 | units on a scale | |
| Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 0 | Combivent Inhalation Aerosol | 5.9 | Standard Deviation 1.24 | units on a scale | |
| Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 0 | Atrovent + Albuterol Aerosols | 5.8 | Standard Deviation 1.10 | units on a scale | |
| Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | Combivent Respimat | 6.2 | Standard Error 0.08 | unit on a scale | |
| Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | Combivent Inhalation Aerosol | 6.1 | Standard Error 0.08 | unit on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01019694/results